A clinical-stage biotechnology company commercializing a novel vaccination platform technology, today announced the opening of its first, state-of-the-art manufacturing facility in Brisbane, Queensland. The custom-built 5,500 square meter (60,000 square feet) Vaxxas Biomedical Facility will serve as the company’s global…
The global life science instrumentation market size was valued at USD 68336.6 million in 2021 and is poised to grow from USD 72858.98 million in 2022 to USD 107344.2 million by 2030, growing at a CAGR of 6.5% in the…
The International Niemann-Pick Disease Registry (INPDR) and biopharmaceutical company Mandos Health today announce a new collaboration giving Mandos Health controlled access to registry information via INPDR’s research “Gateway” platform. This partnership will provide Mandos Health with real-world evidence that will…
Trilliant Health, the healthcare industry’s leading predictive analytics and market research firm, today released the 2023 SimilarityIndex™ | Hospitals, the health economy’s only data-driven hospital benchmarking analysis. SimilarityIndex™ | Hospitals uses machine learning models to identify the 50 most similar peer…
Podimetrics, creator of the SmartMat™ and integrated clinical and patient support services that can help save the limbs and lives of people living with complex diabetes, today announced Barbara Greising will be joining the Podimetrics executive leadership team as Chief Commercial Officer.…
TheSojitz Corporation (“Sojitz”) has signed a memorandum of understanding with HIROTSU Bioscience Inc. (“HIROTSU”), a developer and provider of N-NOSE®, a primary cancer screening test offering early cancer detection, the WHO Foundation (“WHO Foundation”), OurCrowd, a venture capital firm and the Global Health Equity Fund (“GHEF”), a fund…
A leading global life sciences company, today announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”), has launched an offering of senior secured notes due 2030 (the “Notes”), subject to market conditions and other customary factors, in connection with the…
A leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent member. Dr. Rothman’s appointment is effective June 6, 2023, at which time the Board will expand to 12 directors, 11 of whom are…
MWI Animal Health, a part of AmerisourceBergen and a leading distributor of animal health products, today unveiled an updated and expanded version of its pet wellness web and mobile application platform, the PetPage® Patient Portal. Offered through AllyDVM, MWI’s cloud-based…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved a new indication for PREVYMIS® (letermovir) for prophylaxis of cytomegalovirus (CMV) disease in adult kidney transplant recipients…
a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced distant metastasis-free survival (DMFS) results from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical trial evaluating mRNA-4157 (V940), an…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the pivotal Phase 3 KEYNOTE-671 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, as a perioperative treatment regimen, which includes treatment before surgery (neoadjuvant)…